MEDICINOVA, INC. Increase (Decrease) in Operating Liabilities
MEDICINOVA, INC. (MNOV) reported Increase (Decrease) in Operating Liabilities of $330.49 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLiabilities · last filed 2021-11-12
- MEDICINOVA, INC. increase (decrease) in operating liabilities for the quarter ending 2021-09-30 was -$16.74K.
- MEDICINOVA, INC. increase (decrease) in operating liabilities for the quarter ending 2021-06-30 was $726.10K, a 21.65% decline year-over-year.
- MEDICINOVA, INC. increase (decrease) in operating liabilities for the quarter ending 2021-03-31 was -$378.87K.
- MEDICINOVA, INC. increase (decrease) in operating liabilities for the quarter ending 2020-12-31 was $189.82K, a 56.74% decline year-over-year.
- MEDICINOVA, INC. increase (decrease) in operating liabilities for fiscal 2020 was -$224.31K, a 215.57% decline from fiscal 2019.
- MEDICINOVA, INC. increase (decrease) in operating liabilities for fiscal 2019 was $194.10K.
- MEDICINOVA, INC. increase (decrease) in operating liabilities for fiscal 2018 was -$663.67K, a 153.24% decline from fiscal 2017.
- MEDICINOVA, INC. increase (decrease) in operating liabilities for fiscal 2017 was $1.25M, a 878.72% increase from fiscal 2016.
| Period end | Increase (Decrease) in Operating Liabilities 3 month | Increase (Decrease) in Operating Liabilities 6 month | Increase (Decrease) in Operating Liabilities 9 month | Increase (Decrease) in Operating Liabilities 9 month as first filed | Increase (Decrease) in Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | -$16.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $709.36K derived: sum of 2 quarters · filed 2021-11-12 | $330.49K 10-Q · filed 2021-11-12 | $520.32K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2021-06-30 | $726.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $347.23K 10-Q · filed 2021-08-12 | $537.06K derived: sum of 3 quarters · filed 2021-08-12 | -$310.31K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2021-03-31 | -$378.87K 10-Q · filed 2021-05-13 | -$189.04K derived: sum of 2 quarters · filed 2021-05-13 | -$1.04M derived: sum of 3 quarters · filed 2021-11-12 | -$109.72K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-12-31 | $189.82K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$657.54K derived: sum of 2 quarters · filed 2021-11-12 | $269.15K derived: sum of 3 quarters · filed 2021-11-12 | -$224.31K 10-K · filed 2021-02-19 | |
| 2020-09-30 | -$847.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $79.33K derived: sum of 2 quarters · filed 2021-11-12 | -$414.14K 10-Q · filed 2021-11-12 | -$576.12K 10-Q · filed 2020-10-26 | $24.68K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $926.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $433.22K 10-Q · filed 2021-08-12 | $872.05K derived: sum of 3 quarters · filed 2021-08-12 | $776.15K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$493.46K 10-Q · filed 2021-05-13 | -$54.64K derived: sum of 2 quarters · filed 2021-05-13 | -$150.53K derived: sum of 3 quarters · filed 2021-05-13 | $628.66K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $438.82K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $342.93K derived: sum of 2 quarters · filed 2021-02-19 | $1.12M derived: sum of 3 quarters · filed 2021-02-19 | $194.10K 10-K · filed 2021-02-19 | |
| 2019-09-30 | -$95.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $683.30K derived: sum of 2 quarters · filed 2020-10-26 | -$244.72K 10-Q · filed 2020-10-26 | $144.12K derived: sum of 4 quarters · filed 2020-10-26 | |
| 2019-06-30 | $779.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$148.83K 10-Q · filed 2020-07-28 | $240.01K derived: sum of 3 quarters · filed 2020-07-28 | $478.01K derived: sum of 4 quarters · filed 2020-07-28 | |
| 2019-03-31 | -$928.03K 10-Q · filed 2020-04-23 | -$539.18K derived: sum of 2 quarters · filed 2020-04-23 | -$301.19K derived: sum of 3 quarters · filed 2020-04-23 | $194.39K derived: sum of 4 quarters · filed 2020-04-23 | |
| 2018-12-31 | $388.84K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $626.84K derived: sum of 2 quarters · filed 2020-02-13 | $1.12M derived: sum of 3 quarters · filed 2020-02-13 | -$663.67K 10-K · filed 2020-02-13 | |
| 2018-09-30 | $238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-24 | $733.57K derived: sum of 2 quarters · filed 2019-10-24 | -$1.05M 10-Q · filed 2019-10-24 | $90.87K derived: sum of 4 quarters · filed 2019-10-24 | |
| 2018-06-30 | $495.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$1.29M 10-Q · filed 2019-07-25 | -$147.13K derived: sum of 3 quarters · filed 2019-07-25 | $170.90K derived: sum of 4 quarters · filed 2019-07-25 | |
| 2018-03-31 | -$1.79M 10-Q · filed 2019-04-25 | -$642.70K derived: sum of 2 quarters · filed 2019-04-25 | -$324.67K derived: sum of 3 quarters · filed 2019-04-25 | $72.32K derived: sum of 4 quarters · filed 2019-04-25 | |
| 2017-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $1.46M derived: sum of 2 quarters · filed 2019-02-13 | $1.86M derived: sum of 3 quarters · filed 2019-02-13 | $1.25M 10-K · filed 2019-02-13 | |
| 2017-09-30 | $318.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $715.03K derived: sum of 2 quarters · filed 2018-10-25 | $103.25K 10-Q · filed 2018-10-25 | $353.24K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-06-30 | $397.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-23 | -$214.78K 10-Q · filed 2018-07-23 | $35.21K derived: sum of 3 quarters · filed 2019-02-13 | $86.55K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2017-03-31 | -$611.78K 10-Q · filed 2018-04-25 | -$361.79K derived: sum of 2 quarters · filed 2019-02-13 | -$310.45K derived: sum of 3 quarters · filed 2019-02-13 | -$45.12K derived: sum of 4 quarters · filed 2019-02-13 | |
| 2016-12-31 | $249.99K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $301.33K derived: sum of 2 quarters · filed 2019-02-13 | $566.66K derived: sum of 3 quarters · filed 2019-02-13 | $127.37K 10-K · filed 2019-02-13 | |
| 2016-09-30 | $51.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-23 | $316.67K derived: sum of 2 quarters · filed 2017-10-23 | -$122.62K 10-Q · filed 2017-10-23 | ||
| 2016-06-30 | $265.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | -$173.96K 10-Q · filed 2017-07-26 | |||
| 2016-03-31 | -$439.29K 10-Q · filed 2017-04-26 | ||||
| 2015-12-31 | -$109.28K 10-K · filed 2018-02-13 | ||||
| 2014-12-31 | $1.15M 10-K · filed 2017-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |